Mirabegron
- PDF / 169,641 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 48 Downloads / 193 Views
1 S
Thrombotic microangiopathy secondary to haemolytic uremic syndrome: case report A 75-year-old man developed thrombotic microangiopathy (TMA) secondary to haemolytic uremic syndrome (a-HUS) during treatment with mirabegron. The man presented with one week history of fatigue, oliguria and non-bloody diarrhoea. In the past (4 years prior), he experienced an episode of TMA secondary to a-HUS. His current findings revealed increased level of LDH and creatinine, haemoglobin of 126, platelets of 125 [sic], haptoglobin
Data Loading...
